Accueil・Liste d'Actions・Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc

Fermé

4.65 0.87

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.42

Max

4.74

Chiffres clés
By Trading Economics
Revenu	-136K -35M
BPA	-0.503
Employés	106
EBITDA	2.2M -35M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+56.1% upside

Dividendes
By Acuity
Prochains Résultats	4 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	26M 321M
Ouverture précédente	3.78
Clôture précédente	4.65

Zentalis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 juil. 2026, 23:56 UTC

LifeVantage Corp shares are trading lower in after-market hours. No specific news was identified to explain this movement.

29 juil. 2026, 23:56 UTC

Zoom Video Communications Inc is trading lower in after-market hours. Broader market uncertainty regarding future interest rate decisions may be influencing investor sentiment.

29 juil. 2026, 23:56 UTC

Harrow Inc shares are lower in after-market hours amid broad weakness in the Pharmaceuticals sub-sector, with the price significantly below its 20-day moving average.

29 juil. 2026, 23:56 UTC

Sprinklr Inc. shares are higher in after-market trading, continuing an upward trajectory amid positive market sentiment following the Federal Reserve's expected interest rate decision.

29 juil. 2026, 23:56 UTC

Becton Dickinson and Co shares are higher in after-market hours, maintaining momentum from Wednesday's close amid uncertainty over future interest rate decisions.

29 juil. 2026, 23:56 UTC

News

Industrial Logistics Properties Trust shares declined after second-quarter results missed expectations, reporting a loss of -$0.22 per share and revenue of $114.12 million.

29 juil. 2026, 23:56 UTC

Archer-Daniels-Midland shares are higher in after-hours trading, reflecting stability despite no specific news to explain the movement.

29 juil. 2026, 23:56 UTC

Correlated Moves

Corsair Gaming Inc shares are higher in after-market trading, supported by positive sentiment and strength in small-cap stocks, including the Russell 2000 Index.

29 juil. 2026, 23:56 UTC

Standard BioTools Inc. shares traded roughly flat during after-market hours, showing little change since Wednesday's close amid a stable trading range.

29 juil. 2026, 23:56 UTC

Axon Enterprise Inc. shares advanced slightly in after-market trading, reflecting routine performance, though they remain below their 20-day moving average.

29 juil. 2026, 23:56 UTC

Correlated Moves

Pentair PLC shares are higher in after-market trading, reflecting a positive trend in the Russell 2000 Index and steady interest rates from the Federal Reserve.

29 juil. 2026, 23:56 UTC

Correlated Moves

Cloudflare Inc. trades higher in after-market hours, reflecting strength near its one-month range. The move aligns with trends in the cybersecurity sector.

29 juil. 2026, 23:56 UTC

Clorox Co. shares declined in after-market trading, despite recovering from earlier lows. The stock remains above its 20-day moving average.

29 juil. 2026, 23:56 UTC

Correlated Moves

Okta Inc shares rose in after-market trading, reflecting positive momentum in the cybersecurity sector and broader market sentiment regarding steady interest rates.

29 juil. 2026, 23:56 UTC

Correlated Moves

DR Horton shares are higher in after-market trading, supported by a rising Russell 2000 Index and stable interest rate expectations from the Federal Reserve.

29 juil. 2026, 23:56 UTC

Trade Desk Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average after four consecutive higher daily closes.

29 juil. 2026, 23:56 UTC

Powell Industries shares are higher in after-market trading, despite a generally flat cumulative return and ongoing uncertainty regarding interest rates.

29 juil. 2026, 23:56 UTC

News

Adobe shares rose after-market, reaching about $263.62. Elevated options volume and a lower put/call ratio reflect bullish sentiment.

29 juil. 2026, 23:56 UTC

Correlated Moves

Energy Fuels Inc shares are higher in after-market hours, reflecting a correlation with Cameco Corp's recent gains amid broader market uncertainty over interest rates.

29 juil. 2026, 23:56 UTC

AeroVironment Inc shares are higher in after-market trading, reflecting a modest gain since Wednesday's close amid cautious market sentiment regarding interest rate expectations.

29 juil. 2026, 23:56 UTC

Campbell Soup Co. shares traded higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

29 juil. 2026, 23:56 UTC

Correlated Moves

ETF Constituents

Macro News

Financial Select Sector SPDR Fund trades higher in after-market hours, supported by gains from key holdings and a rise in the Dow Jones Index.

29 juil. 2026, 23:56 UTC

Alcoa Corp shares advanced modestly in after-market trading following Wednesday's close, amid uncertainty over future interest rate changes.

29 juil. 2026, 23:56 UTC

Correlated Moves

Lennar Corp sees a modest increase in after-market trading, supported by positive market sentiment and a rise in the Russell 2000 Index.

29 juil. 2026, 23:56 UTC

Alphabet Inc. shares declined in after-market trading, reflecting a cumulative drop since Wednesday's close and remaining below the 20-day moving average.

29 juil. 2026, 23:56 UTC

Social Media

Alphabet Inc shares declined in after-market trading, remaining below their 20-day moving average amid ongoing market uncertainty about future rate hikes.

29 juil. 2026, 23:56 UTC

Macro Event

Cardano is higher today amid expectations of a future Fed rate hike, despite ongoing geopolitical tensions and easing inflation data.

29 juil. 2026, 23:56 UTC

News

Logitech International SA's quarterly report filing has led to shares trading higher in after-market hours, reflecting increased investor interest.

29 juil. 2026, 23:56 UTC

Macro News

ETF Constituents

Utilities Select Sector SPDR Fund trades higher in after-market hours, buoyed by strong returns from NextEra Energy and Entergy amid rising geopolitical tensions.

29 juil. 2026, 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

Comparaison

Variation de prix

Zentalis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

56.1% hausse

Prévisions sur 12 Mois

Moyen 7.29 USD 56.1%

Haut 11 USD

Bas 4 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

8 ratings

Achat

Maintien

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.